. 2011 Jul 21;67(1):34–37. doi: 10.1016/S0377-1237(11)80008-0

Table 1.

Age distribution of thalassemia patients

Age group (year)	Non-ALLO^* (%)	ALLO^* (%)	Total studied (%)
0-4	5 (15.6%)	-	5 (15.6%)
5-9	13 (40.6%)	2 (6.3%)	15 (46.9%)
10-14	8 (25%)	3 (9.4%)	11 (34.4%)
15-19	0	1 (3.1%)	1 (32.2%)
Total	26 (81.2%)	6 (18.8%)	32 (100%)

ALLO-alloimmunized